Clinical Guides
Menorrhagia and Heavy Menstrual Bleeding
An India-adapted guide to evaluating menstrual blood loss that disrupts life, finding its cause, correcting anaemia and choosing management with reproductive goals and safety in view.
MedNext Academy | 12 min read
Menorrhagia and Heavy Menstrual Bleeding
An India-adapted guide to evaluating menstrual blood loss that disrupts life, finding its cause, correcting anaemia and choosing management with reproductive goals and safety in view.
Summary
Menorrhagia is commonly used for menstrual bleeding that is excessive in amount or duration; current practice more usefully asks whether heavy menstrual bleeding (HMB) interferes with physical, social, emotional or material quality of life. A patient may describe flooding, double protection, changing products hourly, passing large clots, avoiding work or school, fatigue, or fear of leaving home. The clinician should take those reports seriously without demanding a measured volume. HMB can be a manifestation of fibroids, adenomyosis, a polyp, ovulatory dysfunction, endometrial disease, coagulopathy, medication effect or pregnancy-related pathology, and it can cause iron deficiency even before anaemia is obvious.
The first decision is whether the person is stable. Acute haemorrhage, syncope, chest pain, breathlessness at rest, severe pallor, pregnancy possibility or severe pelvic pain needs urgent assessment. In a stable patient, a structured history, blood count and cause-directed examination and imaging make management safer. Options include non-hormonal treatment during bleeding, hormonal therapy, a levonorgestrel intrauterine system, correction of iron deficiency and procedures selected for the underlying cause and fertility wishes. This MedNext Clinical Team draft is reviewed educational guide; its organisational review body has not completed clinical approval.
How Common Is It?
Heavy menstrual bleeding is a frequent reason for gynaecology consultation, but prevalence numbers vary because studies use different definitions: self-reported heaviness, pictorial charts, duration, iron deficiency or interference with daily life. A single numeric threshold cannot capture the patient who remains housebound during every period despite a seemingly ordinary product count. current guidelines deliberately frames HMB by quality-of-life effect rather than insisting that blood loss be measured. That approach is clinically practical and prevents the false reassurance created by a normal pelvic examination.
India does not have one current national surveillance figure that represents every age group, setting, contraceptive practice, structural cause or access barrier. Community reports, outpatient samples and hospital procedure data answer different questions. Avoid claiming that an imported percentage is an Indian population prevalence. The workload is nevertheless substantial because delayed presentation is common when bleeding is normalised, sanitary products are unaffordable, anaemia symptoms are accepted as routine or access to gynaecology is difficult. The consequence is often greater than the immediate blood loss: poor attendance, reduced work capacity, sexual distress, iron deficiency, repeated emergency visits and delayed diagnosis of structural disease. Clinical importance should be assessed from impact, haemodynamic state and cause, not from whether a patient can estimate millilitres.
Risk Factors
A useful cause framework is FIGO PALM-COEIN. Structural causes are polyp, adenomyosis, leiomyoma and malignancy or hyperplasia; non-structural causes are coagulopathy, ovulatory dysfunction, endometrial disorders, iatrogenic causes and not-yet-classified disorders. Age, reproductive stage and symptoms alter probability. An adolescent with heavy bleeding from menarche, easy bruising, epistaxis, gum bleeding, excessive bleeding after dental work or a family history needs consideration of an inherited bleeding disorder. A person with obesity, prolonged irregular cycles or features of androgen excess may have ovulatory dysfunction and endometrial exposure to unopposed oestrogen.
Fibroids and adenomyosis become more likely with increasing reproductive age, bulk symptoms, pressure, dysmenorrhoea or an enlarged uterus. Intermenstrual bleeding, postcoital bleeding, a new bleeding pattern in later reproductive life, failed treatment or risk factors for endometrial pathology require careful escalation; they are not automatically “fibroids.” Pregnancy must be excluded whenever relevant. Ask specifically about anticoagulants, antiplatelets, hormonal preparations, copper intrauterine devices and medicines that affect ovulation or haemostasis. The FOGSI-affiliated recommendations support structured history for coagulopathy and systematic classification, but no single checklist replaces clinical examination and a pregnancy test when indicated. Risk is a guide to focused investigation, not a label applied before listening to the patient.
Diagnosis
History
Ask the patient what an ordinary period was like before the change, cycle interval, duration, number of days of flooding, clots, overnight leakage, product use and practical consequences. Record last menstrual period, possibility of pregnancy, pelvic pain, dyspareunia, pressure, discharge, postcoital and intermenstrual bleeding. Ask about fatigue, dizziness, exertional breathlessness, palpitations and pica. Clarify contraception, pregnancy intentions, previous procedures, medicines and prior blood results. Screen for coagulopathy when bleeding began at menarche or there is personal or family bleeding history.
Examination
Assess pulse, blood pressure, pallor, body mass, thyroid features where appropriate and signs of androgen excess or bleeding tendency. Abdominal and pelvic examination should be consented, chaperoned and targeted: assess tenderness, uterine size and mobility, cervical lesions, vaginal pathology or a palpable mass. It may be deferred in some young people when history is reassuring and a procedure would not alter immediate management. A painful enlarged or irregular uterus changes the imaging question; it does not establish a diagnosis by itself.
Investigations
Obtain a full blood count for all HMB; ferritin is useful when iron deficiency is suspected or symptoms persist despite a non-anaemic count. Pregnancy testing, STI tests, coagulation testing, thyroid tests and endocrine assays should follow history rather than become reflex panels. Current guidelines recommends hysteroscopy when cavity pathology is suspected and ultrasound for mass, adenomyosis or a difficult examination. Endometrial sampling is selected by risk and performed with appropriate visual assessment; blind sampling for every patient is not a substitute for clinical reasoning.
Differential Diagnosis
HMB is a symptom, not a synonym for dysfunctional uterine bleeding. Pregnancy-related bleeding, miscarriage and ectopic pregnancy must be considered whenever conception is possible, especially with pain, dizziness or a late period. Cervicitis, cervical lesion, vaginal trauma and urinary or rectal bleeding can be misidentified as menstrual blood loss. A person who reports “continuous periods” may have anovulatory irregular bleeding, an intracavitary lesion, hormonal breakthrough bleeding or a systemic disorder rather than true cyclic menorrhagia.
Structural lesions need differentiation. Submucosal fibroids and polyps can produce regular heavy bleeding, adenomyosis often combines HMB with dysmenorrhoea and a bulky tender uterus, while uterine malignancy or hyperplasia is less common but must not be missed in people with risk factors or unusual patterns. Endometriosis predominantly causes pain and may coexist with another reason for heavy bleeding. A bleeding disorder is especially important in adolescents and those with lifelong heavy periods, but acquired anticoagulant-related bleeding and liver or renal disease can also contribute.
The differential should protect against two opposite errors: ordering a scan for every stable young person with no suggesting features, or repeatedly prescribing tablets while overlooking cancer risk, pregnancy or severe anaemia. Decide whether the immediate issue is haemorrhage, whether the uterus or cervix needs visualisation, whether ovulation is regular, and whether systemic bleeding risk is plausible. The FOGSI PALM-COEIN structure helps organise this reasoning without pretending that every patient has only one cause.
Management
Management begins with the patient’s goal: fewer bleeding days, reliable contraception, pregnancy preservation, pain relief, anaemia correction or definitive treatment. Explain the suspected cause, uncertainties and alternatives in language that permits an informed choice. In stable HMB without a major cavity-distorting lesion, current guidelines lists the levonorgestrel-releasing intrauterine system as an important first option for many patients, with tranexamic acid, NSAIDs, combined hormonal contraception and cyclical oral progestogens among alternatives when appropriate. Choice depends on contraindications, bleeding pattern, need for contraception, uterine anatomy, time to benefit and preference.
Treat iron deficiency alongside bleeding control. Dietary advice alone does not correct significant deficiency; use oral or intravenous iron according to severity, tolerance, absorption, anticipated response and local protocol. Severe symptomatic anaemia or haemodynamic compromise requires urgent senior assessment and a facility-specific blood-management pathway. Fibroids, polyps, adenomyosis and suspected malignancy may need hysteroscopic treatment, myomectomy, uterine artery embolisation, endometrial ablation or hysterectomy according to diagnosis and fertility plans. Endometrial ablation and hysterectomy are not contraceptive shortcuts and need counselling about future pregnancy.
Acute heavy bleeding needs resuscitation, pregnancy exclusion, crossmatch where necessary, cause-directed medical treatment and early gynaecology involvement. The FOGSI recommendation is Indian professional consensus, while exact emergency regimens and transfusion thresholds require local hospital policy. Do not allow an outpatient HMB algorithm to delay care for shock, severe anaemia symptoms or suspected ectopic pregnancy.
Prescribing Information
Tranexamic acid is a non-hormonal option used during bleeding days in selected stable patients; prescribers must check thrombosis history, renal impairment, concurrent risks and local dosing policy. NSAIDs can reduce menstrual blood loss and dysmenorrhoea for suitable patients, but avoid them where renal disease, peptic ulcer disease, allergy, relevant anticoagulation or bleeding risk makes harm more likely. Combined hormonal contraception requires standard assessment of venous thromboembolism risk, migraine with aura, smoking, hypertension, postpartum status and drug interactions. Progestogen regimens and the levonorgestrel intrauterine system require counselling about expected bleeding changes, adherence, contraindications and when to seek review.
Iron is treatment, not merely a supplement. Confirm preparation, elemental iron plan, adherence barriers, gastrointestinal adverse effects and the response timeline. Consider intravenous replacement under local guidance when oral therapy is not tolerated, absorption is poor, blood loss is ongoing or rapid correction is clinically required. Do not write a generic prescription before checking pregnancy status when relevant, current contraception, haemoglobin and the possibility of an underlying lesion.
This guide does not prescribe a universal dose, duration or transfusion threshold. The cited current guidelines guideline reflects UK practice and the 2026 FOGSI-affiliated paper is professional consensus rather than an Indian national formulary. Prescribing should follow an authorised Indian formulary, local protocol and specialist advice. Safety-net every medicine: new chest pain, unilateral leg swelling, severe headache, allergy, unbearable bleeding or pregnancy concern requires prompt reassessment rather than repeated unsupervised courses.
When to Refer
Refer urgently to emergency or gynaecology services for haemodynamic instability, syncope, active heavy bleeding with severe symptoms, haemoglobin-related cardiopulmonary symptoms, possible ectopic pregnancy, acute severe pelvic pain, fever with pelvic tenderness or a suspected malignancy. The referral should state bleeding tempo, pregnancy possibility and test result, vital signs, haemoglobin, blood group and crossmatch status where available, medicines given, anticoagulant use, pain, examination findings and relevant comorbidity. “Heavy periods” is an inadequate handover when immediate risk exists.
Arrange routine or expedited gynaecology review when treatment does not improve quality of life, the uterus is enlarged or irregular, a pelvic mass is suspected, bleeding is intermenstrual or postcoital, the patient has significant anaemia, imaging suggests cavity pathology, or fertility-preserving procedural options need discussion. Adolescents with a likely bleeding disorder need coordinated gynaecology and haematology input. A person with persistent abnormal bleeding and endometrial-risk factors needs an investigation plan rather than escalating empirical hormone courses indefinitely.
Referral boundaries differ across India according to ultrasound, hysteroscopy, blood-bank and specialist access. The cited international and professional guidance can inform what needs escalation but cannot dictate a local destination. Where transport is prolonged, stabilise, give a clear transfer note and communicate with the receiving unit early. A patient’s preference for conservative treatment should be respected, but it does not remove the duty to investigate warning patterns.
Red Flags
A soaked pad every hour, rapid passage of large clots, fainting, collapse, chest pain, breathlessness at rest, confusion, marked tachycardia, hypotension or signs of poor perfusion may represent dangerous blood loss or severe anaemia. Start emergency assessment rather than asking the patient to complete a menstrual diary. Pregnancy possibility with pain, shoulder-tip pain, dizziness or heavy bleeding needs ectopic pregnancy exclusion. Fever, offensive discharge, cervical motion tenderness or severe pelvic pain can indicate infection requiring a different urgent pathway.
Postmenopausal bleeding, postcoital bleeding, persistent intermenstrual bleeding, unexplained weight loss, a suspicious cervical appearance, rapidly enlarging pelvic mass or failed medical treatment with risk factors for endometrial disease should trigger malignancy-conscious assessment. These patterns are not proof of cancer, but reassurance without visualisation or referral can be harmful. Young age does not make a patient immune to serious disease, and older age does not make all bleeding “the menopause.”
Bleeding since menarche with bruising, frequent nosebleeds, dental or surgical bleeding, postpartum haemorrhage history or family members with abnormal bleeding is a coagulopathy signal. New heavy bleeding after starting an anticoagulant also needs medication review and coordinated care. The FOGSI source supports this targeted history. Red flags identify who needs urgent physiology and cause assessment; they should not be used to shame a patient for reporting menstrual symptoms.
Indian Clinical Context
The 2026 FOGSI-affiliated good clinical practice recommendations are the most directly India-oriented condition source used here. They are professional consensus published in a journal, not a binding national government protocol. current guidelines is UK guidance. Together they support careful history, PALM-COEIN thinking and shared management choices, but they do not establish one Indian price, referral interval, transfusion trigger, formulation availability or service pathway. Local public-sector and private-sector access to ultrasound, hysteroscopy, levonorgestrel systems, iron infusion and surgery varies widely.
Anaemia, transport barriers, menstrual stigma and cost of products can amplify the impact of bleeding. Ask about school or work absence, ability to obtain medicines, privacy, violence and reproductive intention without assuming any answer. Correct information about contraception and fertility is essential: treatment can be chosen with future pregnancy in mind, while some procedures permanently change options. A referral plan should account for the nearest capable facility and whether the person can return urgently.
NMC 2024 supports undergraduate learning but does not give a condition-specific drug regimen. This review-queue draft is not a prescription standard and does not claim clinical endorsement. It is held under organisational MedNext Clinical Team governance, awaiting independent review, with reviewed containment until any future approved publication process is completed.
NMC Competency Mapping
NMC CBME 2024 competency OG24.1 requires the learner to classify and discuss abnormal uterine bleeding, its aetiology, features, investigation, diagnosis and management. Menorrhagia is therefore a useful case for history taking that is both technically accurate and non-judgemental. A learner should ask about cycle pattern, flooding, clots, impact, pregnancy risk, medications and bleeding history; assess stability; and recognise that a patient’s reported loss and fatigue deserve attention even without an objective volume measurement.
In a clinical skills exercise, a stable patient with regular very heavy periods can be used to test PALM-COEIN classification, full blood count interpretation, iron management, pelvic-examination consent and selection of ultrasound or hysteroscopy from the history. A second exercise can describe an adolescent with heavy bleeding from menarche and test recognition of possible coagulopathy and appropriate referral. A third can require an emergency handover for active severe bleeding, including vital signs and pregnancy status.
The curriculum is not a list of universally correct doses, device brands or operative indications. Students should learn to use local formulary and senior supervision for tranexamic acid, hormones, iron, transfusion and emergency treatment. Assessment should reward safety-netting, respect for confidentiality and reproductive choice, rather than a rote list that forgets instability or cancer-risk symptoms.
Key Exam Pearls for NEET PG
Heavy menstrual bleeding is assessed by its impact on quality of life; it need not be quantified in millilitres to be clinically important. PALM-COEIN divides causes into structural polyp, adenomyosis, leiomyoma and malignancy/hyperplasia, then coagulopathy, ovulatory dysfunction, endometrial, iatrogenic and not-yet-classified causes. A full blood count is appropriate for all patients with HMB. Pregnancy testing, coagulation studies, thyroid testing and imaging should be selected from the history and examination rather than ordered indiscriminately.
Adolescent HMB from menarche with mucocutaneous or family bleeding history suggests an inherited bleeding disorder. Regular heavy bleeding with bulk symptoms suggests fibroids; HMB plus dysmenorrhoea and a bulky tender uterus may suggest adenomyosis. Intermenstrual or postcoital bleeding and endometrial-risk features require a malignancy-conscious pathway. Acute instability is an emergency, not a question about first-line long-term therapy.
For stable patients without major cavity distortion, a levonorgestrel intrauterine system is a major first-line option in current guidelines guidance when suitable and acceptable. Tranexamic acid, NSAIDs, combined hormonal contraception and cyclical progestogens are alternatives selected by contraindications and goals. Correct iron deficiency in parallel. Remember that ablation and hysterectomy have fertility consequences, and that UK guidance must be adapted to Indian availability and local policy.
Frequently Asked Questions
Is a very heavy period always caused by fibroids?
No. Fibroids are one structural cause, but adenomyosis, polyps, ovulatory dysfunction, bleeding disorders, medicines, pregnancy-related conditions and endometrial pathology can also cause heavy bleeding. The pattern, age, pain, examination, blood count and appropriate imaging determine which causes require investigation and whether urgent specialist care is needed.
When should someone seek urgent care for menstrual bleeding?
Urgent assessment is needed for fainting, severe dizziness, chest pain, breathlessness at rest, confusion, very rapid bleeding, severe weakness, pregnancy possibility with pain, or fever and pelvic tenderness. These symptoms may reflect major blood loss, severe anaemia, ectopic pregnancy, infection or another emergency.
Can heavy periods cause iron deficiency without severe anaemia?
Yes. Ongoing menstrual loss can deplete iron stores before haemoglobin falls markedly. Fatigue, reduced exercise tolerance, hair shedding, restless legs or pica may merit assessment in context. Controlling bleeding and replacing iron are complementary; dietary advice alone may not correct clinically important deficiency.
Are all treatment options suitable when future pregnancy is wanted?
No. Treatment should be selected with fertility goals discussed explicitly. Medical treatment and myomectomy may preserve options in suitable cases, whereas endometrial ablation is not intended for people planning pregnancy and hysterectomy ends fertility. Specialist counselling is needed when a procedure is considered.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic